Martin Marietta Materials Inc a un objectif de cours consensuel de $607.3 basé sur les évaluations de 24 analystes. Le plus élevé est $737, publié par Goldman Sachs le avril 16, 2024. Le plus bas est $350, publié par Atlantic Equities le janvier 24, 2023. Les 3 évaluations d’analystes les plus récentes ont été publiées par Stifel, JP Morgan et UBS le novembre 11, 2025, novembre 11, 2025 et novembre 7, 2025, respectivement. Avec un objectif de cours moyen de $701.33 entre Stifel, JP Morgan et UBS, il existe une variation implicite de 15.28% upside pour Martin Marietta Materials Inc selon ces dernières évaluations d’analystes.
1calculé à partir des notes des analystes
Buy Now | Get Alert | |||||||
|---|---|---|---|---|---|---|---|---|
11/11/2025 | 11.93% | Stifel | $637 → $681 | Maintains | Buy | |||
11/11/2025 | 15.06% | JP Morgan | $670 → $700 | Maintains | Neutral | |||
11/07/2025 | 18.84% | UBS | $705 → $723 | Maintains | Buy | |||
11/06/2025 | 0.26% | Wells Fargo | $620 → $610 | Maintains | Equal-Weight | |||
10/21/2025 | 11.77% | Raymond James | $645 → $680 | Maintains | Outperform | |||
10/20/2025 | 10.95% | Barclays | $600 → $675 | Maintains | Overweight | |||
10/08/2025 | 1.91% | Wells Fargo | → $620 | Initiates | → Equal-Weight | |||
08/12/2025 | 4.7% | Stifel | $609 → $637 | Maintains | Buy | |||
08/11/2025 | 15.06% | DA Davidson | $625 → $700 | Maintains | Buy | |||
08/08/2025 | -13.71% | RBC Capital | $515 → $525 | Maintains | Sector Perform | |||
08/08/2025 | 6.02% | Raymond James | $600 → $645 | Maintains | Outperform | |||
08/05/2025 | 5.69% | B of A Securities | $577 → $643 | Maintains | Neutral | |||
07/28/2025 | -0.56% | Morgan Stanley | $576 → $605 | Maintains | Overweight | |||
06/16/2025 | -15.35% | RBC Capital | → $515 | Initiates | → Sector Perform | |||
05/16/2025 | 4.21% | UBS | $548 → $634 | Upgrade | Neutral → Buy | |||
05/06/2025 | -5.33% | Morgan Stanley | $561 → $576 | Maintains | Overweight | |||
05/01/2025 | 0.1% | Stifel | $559 → $609 | Maintains | Buy | |||
04/29/2025 | -1.87% | Raymond James | $600 → $597 | Maintains | Outperform | |||
04/07/2025 | -19.3% | UBS | $690 → $491 | Downgrade | Buy → Neutral | |||
04/01/2025 | 1.08% | Loop Capital | $645 → $615 | Maintains | Buy | |||
03/19/2025 | -7.96% | JP Morgan | $640 → $560 | Downgrade | Overweight → Neutral | |||
03/04/2025 | -8.12% | Stifel | → $559 | Reinstates | → Buy | |||
02/13/2025 | 6.02% | Loop Capital | $680 → $645 | Maintains | Buy | |||
02/13/2025 | -1.38% | Raymond James | $630 → $600 | Maintains | Outperform | |||
02/13/2025 | 6.84% | Stephens & Co. | $675 → $650 | Maintains | Overweight | |||
02/13/2025 | 0.26% | Truist Securities | $670 → $610 | Maintains | Buy | |||
02/13/2025 | -1.38% | Barclays | $645 → $600 | Maintains | Overweight | |||
01/16/2025 | 3.55% | Raymond James | $640 → $630 | Maintains | Outperform | |||
01/06/2025 | -1.38% | Citigroup | $701 → $600 | Maintains | Buy | |||
12/17/2024 | 2.24% | Morgan Stanley | $657 → $622 | Maintains | Overweight | |||
11/27/2024 | 5.19% | JP Morgan | $515 → $640 | Upgrade | Neutral → Overweight | |||
11/07/2024 | 19.99% | UBS | → $730 | Initiates | → Buy | |||
10/31/2024 | 10.95% | Stephens & Co. | $615 → $675 | Maintains | Overweight | |||
10/31/2024 | 11.77% | Loop Capital | $600 → $680 | Maintains | Buy | |||
10/29/2024 | 6.02% | Barclays | $595 → $645 | Maintains | Overweight | |||
10/09/2024 | 4.37% | Jefferies | $650 → $635 | Maintains | Buy | |||
10/09/2024 | -15.35% | JP Morgan | $560 → $515 | Maintains | Neutral | |||
08/26/2024 | 7.99% | Morgan Stanley | $610 → $657 | Maintains | Overweight | |||
08/13/2024 | 1.08% | Loop Capital | $630 → $615 | Maintains | Buy | |||
08/12/2024 | 6.18% | Citigroup | $658 → $646 | Maintains | Buy | |||
08/09/2024 | 0.26% | Stephens & Co. | $650 → $610 | Maintains | Overweight | |||
08/09/2024 | 10.12% | Truist Securities | $700 → $670 | Maintains | Buy | |||
07/17/2024 | 9.3% | Jefferies | $660 → $665 | Maintains | Buy | |||
07/11/2024 | 8.15% | Citigroup | $696 → $658 | Maintains | Buy | |||
07/03/2024 | 3.55% | Loop Capital | $710 → $630 | Maintains | Buy | |||
07/03/2024 | 3.55% | Stifel | $650 → $630 | Maintains | Buy | |||
04/16/2024 | 21.14% | Goldman Sachs | $642 → $737 | Maintains | Buy | |||
04/15/2024 | 6.84% | Stifel | $621 → $650 | Maintains | Buy | |||
04/05/2024 | 16.37% | Citigroup | $635 → $708 | Maintains | Buy | |||
04/02/2024 | 15.06% | Truist Securities | $610 → $700 | Maintains | Buy | |||
03/22/2024 | -1.38% | JP Morgan | $530 → $600 | Downgrade | Overweight → Neutral | |||
03/12/2024 | 10.12% | Seaport Global | $520 → $670 | Maintains | Buy | |||
03/08/2024 | — | Wolfe Research | — | Downgrade | Outperform → Peer Perform | |||
02/22/2024 | -10.75% | HSBC | $376 → $543 | Upgrade | Reduce → Hold | |||
02/16/2024 | -0.56% | Stephens & Co. | $575 → $605 | Maintains | Overweight | |||
02/16/2024 | 5.52% | Goldman Sachs | $560 → $642 | Maintains | Buy | |||
02/16/2024 | 4.37% | Citigroup | $573 → $635 | Maintains | Buy | |||
02/15/2024 | 0.26% | Truist Securities | $550 → $610 | Maintains | Buy | |||
01/25/2024 | -8.78% | Raymond James | $505 → $555 | Maintains | Outperform | |||
01/08/2024 | -2.2% | Morgan Stanley | → $595 | Initiates | → Overweight | |||
12/19/2023 | -1.71% | Stifel | $510 → $598 | Maintains | Buy | |||
12/12/2023 | — | JP Morgan | — | Upgrade | Neutral → Overweight | |||
11/02/2023 | -17% | Raymond James | $490 → $505 | Maintains | Outperform | |||
11/02/2023 | -11.24% | Stephens & Co. | $525 → $540 | Maintains | Overweight | |||
10/24/2023 | -14.53% | Seaport Global | → $520 | Upgrade | Neutral → Buy | |||
10/12/2023 | -19.46% | Raymond James | $484 → $490 | Maintains | Outperform | |||
09/15/2023 | -38.2% | HSBC | → $376 | Initiates | → Reduce | |||
08/24/2023 | -19.46% | JP Morgan | $470 → $490 | Maintains | Neutral | |||
07/28/2023 | -9.6% | Truist Securities | $446 → $550 | Maintains | Buy | |||
07/28/2023 | -20.45% | Raymond James | $416 → $484 | Maintains | Outperform | |||
07/28/2023 | -19.46% | Barclays | $430 → $490 | Maintains | Overweight | |||
07/26/2023 | -13.71% | Stephens & Co. | $475 → $525 | Maintains | Overweight | |||
07/17/2023 | -9.11% | Goldman Sachs | $489 → $553 | Maintains | Buy | |||
07/14/2023 | -13.38% | Citigroup | $460 → $527 | Maintains | Buy | |||
07/13/2023 | -12.89% | Jefferies | $460 → $530 | Maintains | Buy | |||
07/06/2023 | -22.75% | JP Morgan | $450 → $470 | Downgrade | Overweight → Neutral | |||
05/10/2023 | -23.57% | DA Davidson | $450 → $465 | Maintains | Buy | |||
05/08/2023 | -21.93% | Stephens & Co. | $435 → $475 | Maintains | Overweight | |||
05/05/2023 | -22.42% | Goldman Sachs | $428 → $472 | Maintains | Buy | |||
05/05/2023 | -31.62% | Raymond James | $405 → $416 | Maintains | Outperform | |||
04/20/2023 | -36.55% | Morgan Stanley | $390 → $386 | Maintains | Equal-Weight | |||
04/03/2023 | -29.65% | Goldman Sachs | $420 → $428 | Upgrade | Neutral → Buy | |||
02/21/2023 | -35.9% | Morgan Stanley | $397 → $390 | Maintains | Equal-Weight | |||
02/16/2023 | -26.04% | DA Davidson | $380 → $450 | Maintains | Buy | |||
02/16/2023 | -26.04% | Loop Capital | $410 → $450 | Maintains | Buy | |||
02/16/2023 | -33.43% | Raymond James | $389 → $405 | Maintains | Outperform | |||
02/16/2023 | -30.97% | Goldman Sachs | $374 → $420 | Maintains | Neutral | |||
02/10/2023 | — | Seaport Global | — | Initiates | → Neutral | |||
01/25/2023 | -36.06% | Raymond James | $380 → $389 | Maintains | Outperform | |||
01/24/2023 | -42.47% | Atlantic Equities | $375 → $350 | Downgrade | Overweight → Neutral | |||
01/20/2023 | -34.75% | Morgan Stanley | $399 → $397 | Maintains | Equal-Weight | |||
12/19/2022 | -33.43% | Stifel | $400 → $405 | Maintains | Buy | |||
12/14/2022 | -34.42% | Morgan Stanley | $409 → $399 | Downgrade | Overweight → Equal-Weight | |||
12/08/2022 | -35.08% | JP Morgan | $410 → $395 | Maintains | Overweight |
Le dernier objectif de prix pour Martin Marietta Materials (NYSE:MLM) a été rapporté par Stifel le novembre 11, 2025. Le cabinet d'analystes a fixé un objectif de prix pour $681.00 s'attendant à ce que MLM se rise dans les 12 prochains mois (un possible changement de 11.93% upside). 31 cabinets d'analystes ont rapporté des notes au cours de la dernière année.
La dernière note d'analyste pour Martin Marietta Materials (NYSE:MLM) a été fournie par Stifel, et Martin Marietta Materials maintenu leur note buy.
La dernière amélioration pour Martin Marietta Materials Inc a eu lieu le mai 16, 2025 lorsque UBS a augmenté leur objectif de prix à $634. UBS avait précédemment a neutral pour Martin Marietta Materials Inc.
La dernière réduction pour Martin Marietta Materials Inc a eu lieu le avril 7, 2025 lorsque UBS a changé leur objectif de prix de $690 à $491 pour Martin Marietta Materials Inc.
Les analystes arrivent à des évaluations d'actions après avoir effectué des recherches approfondies, ce qui inclut l'examen des états financiers publics, la discussion avec les dirigeants et les clients de Martin Marietta Materials, et l'écoute des conférences téléphoniques sur les résultats. La plupart des analystes font cela tous les trois mois, vous devriez donc obtenir 4 notes par entreprise par société chaque année. La dernière note pour Martin Marietta Materials a été déposée le novembre 11, 2025, donc vous devriez vous attendre à ce que la prochaine note soit disponible vers novembre 11, 2026.
Bien que les évaluations soient subjectives et changeront, la dernière note de Martin Marietta Materials (MLM) était un maintenu avec un objectif de prix de $637.00 à $681.00. Le prix actuel de Martin Marietta Materials (MLM) est de $608.40, ce qui est out of la fourchette prédite par l'analyste.
Parcourir notes d'analystes et objectifs de cours sur toutes les actions.